Literature DB >> 6407180

Detection of Sarcocystis antigens in the sera of experimentally-infected pigs and mice by an immunoenzymatic assay.

P J O'Donoghue, H Weyreter.   

Abstract

Immunoglobulins raised against Sarcocystis miescheriana and Sarcocystis muris cystozoite antigens were isolated from rabbit immune sera by affinity chromatography (using CNBr-activated Sepharose 4B for antigen immobilization). The specific immunoglobulins were incorporated into double-antibody sandwich immuno-enzymatic assays which were firstly quantitated and then used to detect soluble Sarcocystis antigens in the sera of experimentally-infected pigs and mice. Assays employing immunoglobulins attached to the solid-phase at concentrations of 80 micrograms/ml were capable of detecting homologous soluble cystozoite and sporozoite reference antigens at concentrations as low as 8 micrograms/ml. Circulating antigens were detected both in the presence and absence of acute clinical disease in pigs experimentally-infected with high and low doses of S. miescheriana sporocysts. The antigenemia detected was transitory (occurring from 3-20 days post-inoculation: dpi) and coincided well with the sporozoite and merozoite phases of parasite development. Circulating antigens were also detected during subclinical infections in mice (from 4-49 dpi) following their experimental infection with low doses of S. muris sporocysts. Specific immuno-enzymatic assays for circulating Sarcocystis antigens may therefore prove useful in the clinical diagnosis of acute sarcocystosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407180     DOI: 10.1016/0304-4017(83)90084-5

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  1 in total

1.  Antigenic characterisation of monoclonal antibodies against Sarcocystis muris by western blotting and immuno-electron microscopy.

Authors:  N Mencke; P O'Donoghue; R Lumb; P Smith; A M Tenter; P Thümmel; M Rommel
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.